An influenza vaccine produced with the use of insect cells appeared safe and produced an immunogenic response in healthy adults, suggesting promise as an alternative to using embryonated eggs for the development of influenza vaccine, according to a preliminary study in the April 11 issue of JAMA.
A new way of understanding how highly pathogenic avian influenza (HPAI) spreads among farm birds is published today in PLoS ONE. The study could help analyse the success of different control measures in the event of future outbreaks.
St. Jude Children’s Research Hospital has been designated one of six Centers of Excellence for Influenza Research and Surveillance funded by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health.
The Egyptian Ministry of Health and Population has announced three new human cases of avian influenza A(H5N1) virus infection.
Routine infant immunization with pneumococcal conjugate vaccine (PCV7) has caused a 39 percent fall in all-cause pneumonia hospital admission rates for American children under 2, according to an article published in this week?s edition of The Lancet.
Researchers at the University of Pennsylvania School of Medicine & School of Engineering and Applied Science have discovered a better way to deliver drugs to tumors.
The most common cause of infant hospitalization in the United States, respiratory syncytial virus, infects virtually all children by age two. Along with the influenza virus, RSV is a major contributor to the approximately two million infant deaths worldwide caused every year by respiratory infections, according to the World Health Organization.
The U.S. Government through the U.S. Agency for International Development (USAID) announced a three-year contract to bolster international capacity for avian and pandemic influenza response.
A new online simulation to help GPs prepare their practice for a pandemic influenza outbreak has been launched today by a research team based at The Australian National University.
UC Davis today was named a partner in a new $18.5 million national research center that will study influenza viruses with pandemic potential, such as avian influenza H5N1 (“bird flu”).